• Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia

    Источник: Buzz FX / 23 апр 2024 00:36:19   America/Chicago


    Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
    Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
    Rilzabrutinib LUNA 3 phase 3 study met prima
    Read more...
Опубликовать